Concurrent nonavalent human papillomavirus (HPV) vaccination and immune stimulation with imiquimod to treat recalcitrant HPV-associated high grade vaginal intra-epithelial neoplasia

This is the first report describing detailed T cell responses to viral-like proteins contained in an HPV specific vaccine given in combination with Imiquimod for treatment of persistent VAIN2/3. We postulate that stimulation of the innate immune system with Imiquimod and the specific CD4 and CD8T ce...

Full description

Bibliographic Details
Main Authors: R. Farrell, J. Zaunders, IM. Poynten, L. Anderson, L. Evans
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Gynecologic Oncology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578924000298
_version_ 1797234326155296768
author R. Farrell
J. Zaunders
IM. Poynten
L. Anderson
L. Evans
author_facet R. Farrell
J. Zaunders
IM. Poynten
L. Anderson
L. Evans
author_sort R. Farrell
collection DOAJ
description This is the first report describing detailed T cell responses to viral-like proteins contained in an HPV specific vaccine given in combination with Imiquimod for treatment of persistent VAIN2/3. We postulate that stimulation of the innate immune system with Imiquimod and the specific CD4 and CD8T cell responses following HPV vaccination with Gardasil9@ combined to induce clinical remission in a woman with treatment-refractory disease.
first_indexed 2024-03-07T19:09:10Z
format Article
id doaj.art-401a59962a6a4c96adfb68303426e94b
institution Directory Open Access Journal
issn 2352-5789
language English
last_indexed 2024-04-24T16:30:17Z
publishDate 2024-04-01
publisher Elsevier
record_format Article
series Gynecologic Oncology Reports
spelling doaj.art-401a59962a6a4c96adfb68303426e94b2024-03-30T04:39:24ZengElsevierGynecologic Oncology Reports2352-57892024-04-0152101350Concurrent nonavalent human papillomavirus (HPV) vaccination and immune stimulation with imiquimod to treat recalcitrant HPV-associated high grade vaginal intra-epithelial neoplasiaR. Farrell0J. Zaunders1IM. Poynten2L. Anderson3L. Evans4Chris O'Brien Lifehouse Hospital, Camperdown, Sydney, New South Wales 2050, Australia; Sydney Medical School, University of Sydney, New South Wales 2006, Australia; Corresponding author at: ChrisO'Brien Lifehouse Hospital, Camperdown, Sydney, New South Wales 2050, Australia.NSW State Reference Labaoratory for HIV, Centre for Applied Medical Research, St Vincents Hospital, New South Wales, Australia; HIV Epidemiology and Prevention Program, The Kirby Institute, University of NSW Kensington, Sydney, New South Wales 2052, AustraliaHIV Epidemiology and Prevention Program, The Kirby Institute, University of NSW Kensington, Sydney, New South Wales 2052, AustraliaSydney Medical School, University of Sydney, New South Wales 2006, Australia; NSW Health Pathology, Royal Prince Alfred Hospital, Camperdown, Sydney, New South Wales 2050, AustraliaUniversity of NSW Kensington, Sydney, New South Wales 2052, Australia; Department of Clinical Immunology, Allergy and HIV, Liverpool Hospital, South Western Sydney Local Health District, Liverpool Sydney, New South Wales 2170, AustraliaThis is the first report describing detailed T cell responses to viral-like proteins contained in an HPV specific vaccine given in combination with Imiquimod for treatment of persistent VAIN2/3. We postulate that stimulation of the innate immune system with Imiquimod and the specific CD4 and CD8T cell responses following HPV vaccination with Gardasil9@ combined to induce clinical remission in a woman with treatment-refractory disease.http://www.sciencedirect.com/science/article/pii/S2352578924000298Human papillomavirus (HPV)Vaginal intraepitheial neoplasia (VAIN)ImiquimodHPV vaccine
spellingShingle R. Farrell
J. Zaunders
IM. Poynten
L. Anderson
L. Evans
Concurrent nonavalent human papillomavirus (HPV) vaccination and immune stimulation with imiquimod to treat recalcitrant HPV-associated high grade vaginal intra-epithelial neoplasia
Gynecologic Oncology Reports
Human papillomavirus (HPV)
Vaginal intraepitheial neoplasia (VAIN)
Imiquimod
HPV vaccine
title Concurrent nonavalent human papillomavirus (HPV) vaccination and immune stimulation with imiquimod to treat recalcitrant HPV-associated high grade vaginal intra-epithelial neoplasia
title_full Concurrent nonavalent human papillomavirus (HPV) vaccination and immune stimulation with imiquimod to treat recalcitrant HPV-associated high grade vaginal intra-epithelial neoplasia
title_fullStr Concurrent nonavalent human papillomavirus (HPV) vaccination and immune stimulation with imiquimod to treat recalcitrant HPV-associated high grade vaginal intra-epithelial neoplasia
title_full_unstemmed Concurrent nonavalent human papillomavirus (HPV) vaccination and immune stimulation with imiquimod to treat recalcitrant HPV-associated high grade vaginal intra-epithelial neoplasia
title_short Concurrent nonavalent human papillomavirus (HPV) vaccination and immune stimulation with imiquimod to treat recalcitrant HPV-associated high grade vaginal intra-epithelial neoplasia
title_sort concurrent nonavalent human papillomavirus hpv vaccination and immune stimulation with imiquimod to treat recalcitrant hpv associated high grade vaginal intra epithelial neoplasia
topic Human papillomavirus (HPV)
Vaginal intraepitheial neoplasia (VAIN)
Imiquimod
HPV vaccine
url http://www.sciencedirect.com/science/article/pii/S2352578924000298
work_keys_str_mv AT rfarrell concurrentnonavalenthumanpapillomavirushpvvaccinationandimmunestimulationwithimiquimodtotreatrecalcitranthpvassociatedhighgradevaginalintraepithelialneoplasia
AT jzaunders concurrentnonavalenthumanpapillomavirushpvvaccinationandimmunestimulationwithimiquimodtotreatrecalcitranthpvassociatedhighgradevaginalintraepithelialneoplasia
AT impoynten concurrentnonavalenthumanpapillomavirushpvvaccinationandimmunestimulationwithimiquimodtotreatrecalcitranthpvassociatedhighgradevaginalintraepithelialneoplasia
AT landerson concurrentnonavalenthumanpapillomavirushpvvaccinationandimmunestimulationwithimiquimodtotreatrecalcitranthpvassociatedhighgradevaginalintraepithelialneoplasia
AT levans concurrentnonavalenthumanpapillomavirushpvvaccinationandimmunestimulationwithimiquimodtotreatrecalcitranthpvassociatedhighgradevaginalintraepithelialneoplasia